JFA
CRL icon

JNBA Financial Advisors’s Charles River Laboratories CRL Stock Holding History

JNBA Financial Advisors’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-24
Closed -$10K – 826
2021
Q3 		$10K Buy
+24
New +$9.97K ﹤0.01% 515
2016
Q4 		– Sell
-20
Closed -$2K – 672
2016
Q3 		$2K Buy
+20
New +$1.68K ﹤0.01% 1409

Other funds holding CRL

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

JNBA Financial Advisors's CRL Position: Q4 2021 in Review

JNBA Financial Advisors sold out of Charles River Laboratories (CRL) in Q4 2021, closing a stake of 24 shares — an estimated $10K sold.

JNBA Financial Advisors first reported a position in CRL in Q3 2016 and held it in 2 quarters. The position peaked at $10K in Q3 2021. 707 funds tracked by Wall St. Rank hold CRL as of Q4 2021.

  • JNBA Financial Advisors reported no remaining Charles River Laboratories position as of Q4 2021 after selling out during the quarter.
  • JNBA Financial Advisors sold 24 Charles River Laboratories shares in Q4 2021, an estimated $10K.
  • JNBA Financial Advisors first reported a position in Charles River Laboratories in Q3 2016 and held it in 2 quarters.
  • JNBA Financial Advisors's Charles River Laboratories position peaked at $10K in Q3 2021.
  • 707 funds tracked by Wall St. Rank held Charles River Laboratories as of Q4 2021.

Based on JNBA Financial Advisors's 13F filing for Q4 2021, filed 3 Feb 2022.